The Los Angeles Dodgers recently made an official roster adjustment involving their veteran pitcher Clayton Kershaw. Kershaw, a revered figure in the franchise and Major League Baseball, was re-signed last month to a one-year deal worth $5 million, with a player option for 2025 of the same amount. However, due to his ongoing recovery from shoulder surgery in 2023, his contract reflects a relatively modest salary.
In light of a new trade acquisition, the Dodgers made a procedural move, placing Kershaw on the 60-day Injured List (IL) to accommodate the arrival of infielder Andre Lipcius from the Tigers, acquired for cash considerations. This decision underscores Kershaw’s extended absence from the field, with expectations that he will likely miss at least the first half of the upcoming season as he continues rehabilitation.
Despite his injury setback, Kershaw, a former Cy Young and MVP recipient, remains a significant asset for the Dodgers. Should he successfully complete his recovery around midseason, it would mark his 17th season with the team. Prior to his injury, Kershaw demonstrated his elite pitching prowess in 2023, boasting impressive statistics with a 2.46 ERA, 1.06 WHIP, and a strong strikeout-to-walk ratio.
Meanwhile, Lipcius, the incoming infielder, adds versatility to the Dodgers’ roster. Capable of playing second and third base, Lipcius made his MLB debut with the Tigers last year, showcasing promise with a .742 OPS during his brief stint. With a career Triple-A batting average of .281, along with solid on-base skills and some power, Lipcius aligns with the Dodgers’ preference for well-rounded players. Additionally, his ability to play outfield further enhances his chances of securing a spot on the roster.
